Document is current
Any future updates will be listed below
-
Authors
Liu, Yang https://orcid.org/0000-0002-9368-0425
Procter, Simon R.
Pearson, Carl A. B.
Montero, Andrés Madriz
Torres-Rueda, Sergio
Asfaw, Elias
Uzochukwu, Benjamin
Drake, Tom
Bergren, Eleanor
Eggo, Rosalind M.
Ruiz, Francis
Ndembi, Nicaise
Nonvignon, Justice
Jit, Mark
Vassall, Anna
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1202541)
Health Data Reseasrch (MR/S003975/1)
World Health Organization (2022/1236532)
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 13 February 2023
First Online: 8 March 2023
Declarations
:
: Our cost estimation and epidemiological modelling were based on publicly available data sources as well as validation from the authors and therefore did not require ethics approval. The use and collection of data on Nigeria was based on a wider health technology assessment exercise of COVID-19 vaccination which was approved by the University of Nigeria Teaching Hospital Research Ethics Committee (Ref: NHREC/05/01/2008B-FWA00002458-1RB00002323).
: Not applicable. This manuscript does not contain any individual person’s data in any form.
: One of the senior authors of this manuscript, Prof. Mark Jit (who contributed equally with Dr Justice Nonvignon and Prof. Anna Vassall), is an editorial board member of the <i>BMC Medicine</i> for his expertise in <i>Health Economics, Quality and Reporting</i>.We declare no additional competing interests.
